Azelastine — $0 with Membership
Azelastine has an active canonical formulary match. No-additional-cost pricing is subject to its listed supply, quantity, fill, and fulfillment limits.
Azelastine Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | $0 with membership |
| Typical Retail | $130.00 |
Free with membership subject to the listed formulary limits.
About Azelastine
Azelastine is a prescription medication. Ask your doctor if Azelastine is right for you.
Other strengths and forms of Azelastine
Conditions Treated with Azelastine
How to Check Azelastine Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Azelastine at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
What Azelastine is approved for (FDA label)
Azelastine HCl Nasal Spray is indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older, and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older. Azelastine HCl Nasal Spray is an H 1 -receptor antagonist indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older. ( 1 )
Source: Read the full FDA label on DailyMed. Label effective date: March 26, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Dosage forms and strengths for Azelastine (FDA label)
Azelastine HCl Nasal Spray is a nasal spray. Each spray of Azelastine HCl Nasal Spray delivers a volume of 0.137 mL solution containing 137 mcg of azelastine hydrochloride, USP. Azelastine HCl Nasal Spray: 137 mcg of azelastine hydrochloride, USP in each 0.137 mL spray. ( 3 )
Source: FDA prescribing information (DailyMed). Set ID: 77b20c6b-f30f-42a9-a0ef-d5d0bd3feb56. SPL document ID: b5281403-77e2-44a3-966f-d9c9efb86453. Label effective date: March 26, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Azelastine (FDA label)
Use of Azelastine HCl Nasal Spray has been associated with somnolence [ see Warnings and Precautions ( 5.1 ) ]. The most common adverse reactions (≥2% incidence) are: bitter taste, headache, somnolence, dysesthesia, rhinitis, nasal burning, pharyngitis, epistaxis, sinusitis, paroxysmal sneezing, nausea, dry mouth, fatigue, dizziness, and weight increase. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Ascend Laboratories, LLC at 1-877-272-7901 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect rates observed in practice.
Source: FDA prescribing information (DailyMed). Set ID: 77b20c6b-f30f-42a9-a0ef-d5d0bd3feb56. SPL document ID: b5281403-77e2-44a3-966f-d9c9efb86453. Label effective date: March 26, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Azelastine (FDA label)
None. None. ( 4 )
Source: FDA prescribing information (DailyMed). Set ID: 77b20c6b-f30f-42a9-a0ef-d5d0bd3feb56. SPL document ID: b5281403-77e2-44a3-966f-d9c9efb86453. Label effective date: March 26, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Warnings and precautions for Azelastine (FDA label)
Somnolence: Avoid engaging in hazardous occupations requiring complete mental alertness such as driving or operating machinery when taking Azelastine HCl Nasal Spray. ( 5.1 ) Alcohol and other central nervous system (CNS) depressants: Avoid concurrent use with Azelastine HCl Nasal Spray because further decreased alertness and impairment of CNS performance may occur. ( 5.1 ) 5.1 Somnolence in Activities Requiring Mental Alertness In clinical trials, the occurrence of somnolence has been reported in some patients taking Azelastine HCl Nasal Spray [ see Adverse Reactions ( 6.1 ) ]. Patients should be cautioned against engaging in hazardous occupations requiring complete mental alertness and motor coordination such as operating machinery or driving a motor vehicle after administration of Azelastine HCl Nasal Spray.
Source: FDA prescribing information (DailyMed). Set ID: 77b20c6b-f30f-42a9-a0ef-d5d0bd3feb56. SPL document ID: b5281403-77e2-44a3-966f-d9c9efb86453. Label effective date: March 26, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Drug interactions for Azelastine (FDA label)
7.1 Central Nervous System Depressants Concurrent use of Azelastine HCl Nasal Spray with alcohol or other central nervous system depressants should be avoided because reductions in alertness and impairment of central nervous system performance may occur [ see Warnings and Precautions ( 5.1 ) ].
Source: FDA prescribing information (DailyMed). Set ID: 77b20c6b-f30f-42a9-a0ef-d5d0bd3feb56. SPL document ID: b5281403-77e2-44a3-966f-d9c9efb86453. Label effective date: March 26, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.